Carisma Therapeutics Files 2024 10-K Amendment
Ticker: CARM · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1485003
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Carisma Therapeutics filed its 2024 10-K amendment on 4/29/25. Check it for updated financials.
AI Summary
Carisma Therapeutics Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Sesen Bio, Inc., is based in Philadelphia, PA, and operates in the pharmaceutical preparations sector. This amendment was filed on April 29, 2025.
Why It Matters
This filing provides updated financial and operational information for Carisma Therapeutics for the 2024 fiscal year, crucial for investors assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine amendment to a previously filed annual report, not indicating new or significant risks.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-36296 — Commission File Number (Unique identifier for the company's filings with the SEC.)
Key Players & Entities
- Carisma Therapeutics Inc. (company) — Registrant
- Sesen Bio, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-04-29 (date) — Filing date
- Philadelphia, PA (location) — Company address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, filed by Carisma Therapeutics Inc.
When was this amendment filed with the SEC?
This amendment was filed on April 29, 2025.
What was Carisma Therapeutics Inc. formerly known as?
Carisma Therapeutics Inc. was formerly known as Sesen Bio, Inc.
Where is Carisma Therapeutics Inc. located?
Carisma Therapeutics Inc. is located at 3675 Market Street, Suite 401, Philadelphia, PA 19104.
What is the SIC code for Carisma Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Carisma Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding Carisma Therapeutics Inc. (CARM).